Covered recipient · General Payments record
MARIA JOSEPHINA T GOMEZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$2,444.03
- Reported across 76 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $535.37 | 17 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $146.73 | 8 |
| GENZYME CORPORATION | $110.92 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $105.69 | 2 |
| Celltrion USA Inc. | $87.85 | 4 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $43.90 | 1 |
| Ardelyx, Inc. | $40.28 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.90 | 04/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204010483 | CMS |
| ABBVIE INC. | $8.88 | 04/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204010489 | CMS |
| ABBVIE INC. | $10.41 | 06/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204010494 | CMS |
| ABBVIE INC. | $15.27 | 08/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204010499 | CMS |
| ABBVIE INC. | $24.89 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204010505 | CMS |
| ABBVIE INC. | $21.23 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204010510 | CMS |
| ABBVIE INC. | $31.07 | 11/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204010517 | CMS |
| ABBVIE INC. | $26.08 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204010524 | CMS |
| Aimmune Therapeutics, Inc. | $63.78 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249724422 | CMS |
| Aimmune Therapeutics, Inc. | $41.91 | 10/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249724420 | CMS |
| Ardelyx, Inc. | $40.28 | 10/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247914574 | CMS |
| Celltrion USA Inc. | $15.41 | 08/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250841141 | CMS |
| Celltrion USA Inc. | $21.96 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250841146 | CMS |
| Celltrion USA Inc. | $15.96 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250841150 | CMS |
| Celltrion USA Inc. | $34.52 | 12/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250841154 | CMS |
| GENZYME CORPORATION | $110.92 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233528520 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $43.90 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232112883 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.